Global Cancer Immunotherapies Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
- GLO2788377
- 129 Pages
- October 2018
- Medical Devices
Scope of the Report:
This report studies the Cancer Immunotherapies market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cancer Immunotherapies market by product type and applications/end industries.
Rising R&D in cancer immunotherapy is resulting in introduction of advanced treatment options that are more effective and efficient. A paradigm shift from traditional chemotherapies to immunotherapies is propelling the overall market.
The world cancer immunotherapy market is foretold to gain impetus due to rising popularity of patient assistance programs and broad portfolio of promising pipeline drugs. However, there could be more significant factors augmenting the demand in the market. For instance, rise in requirement of cancer monoclonal antibodies and launch of more effective bioinformatics tools offering improved drug development options could help with more demand for cancer immunotherapy. Furthermore, surge in adoption of immunotherapy therapeutics compared to conventional ones and high incidence of cancer could help the market to increase growth in the coming years.
The Americas accounted for approximately 47% of the market share of the global cancer immunotherapies market in 2015. High incidences of cancer in regions like the US, Canada, and Latin America are expected to contribute to the market growth in this region. region. This has led to an increase in consumption of immunotherapies that is used to treat cancer patients, thereby aiding the market growth.
The global Cancer Immunotherapies market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cancer Immunotherapies.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Amgen
Bristol Mayer’s Squibb
F. Hoffmann-La Roche
Merck
Takeda
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Monoclonal Antibodies
Cancer Vaccines
Check Point Inhibitors
Immunomodulators
Market Segment by Applications, can be divided into
Lung
Breast
Colorectal
Melanoma
Prostate
Head & Neck
1 Cancer Immunotherapies Market Overview
1.1 Product Overview and Scope of Cancer Immunotherapies
1.2 Classification of Cancer Immunotherapies by Types
1.2.1 Global Cancer Immunotherapies Revenue Comparison by Types (2017-2023)
1.2.2 Global Cancer Immunotherapies Revenue Market Share by Types in 2017
1.2.3 Monoclonal Antibodies
1.2.4 Cancer Vaccines
1.2.5 Check Point Inhibitors
1.2.6 Immunomodulators
1.3 Global Cancer Immunotherapies Market by Application
1.3.1 Global Cancer Immunotherapies Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Lung
1.3.3 Breast
1.3.4 Colorectal
1.3.5 Melanoma
1.3.6 Prostate
1.3.7 Head & Neck
1.4 Global Cancer Immunotherapies Market by Regions
1.4.1 Global Cancer Immunotherapies Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Cancer Immunotherapies Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Immunotherapies Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Immunotherapies Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Cancer Immunotherapies Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Immunotherapies Status and Prospect (2013-2023)
1.5 Global Market Size of Cancer Immunotherapies (2013-2023)
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.2 Cancer Immunotherapies Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Cancer Immunotherapies Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bristol Mayer’s Squibb
2.2.1 Business Overview
2.2.2 Cancer Immunotherapies Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bristol Mayer’s Squibb Cancer Immunotherapies Revenue, Gross Margin and Market Share (2016-2017)
2.3 F. Hoffmann-La Roche
2.3.1 Business Overview
2.3.2 Cancer Immunotherapies Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 F. Hoffmann-La Roche Cancer Immunotherapies Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 Cancer Immunotherapies Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Cancer Immunotherapies Revenue, Gross Margin and Market Share (2016-2017)
2.5 Takeda
2.5.1 Business Overview
2.5.2 Cancer Immunotherapies Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Takeda Cancer Immunotherapies Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cancer Immunotherapies Market Competition, by Players
3.1 Global Cancer Immunotherapies Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Immunotherapies Players Market Share
3.2.2 Top 10 Cancer Immunotherapies Players Market Share
3.3 Market Competition Trend
4 Global Cancer Immunotherapies Market Size by Regions
4.1 Global Cancer Immunotherapies Revenue and Market Share by Regions
4.2 North America Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
4.3 Europe Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
4.5 South America Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
5 North America Cancer Immunotherapies Revenue by Countries
5.1 North America Cancer Immunotherapies Revenue by Countries (2013-2018)
5.2 USA Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
5.3 Canada Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
5.4 Mexico Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
6 Europe Cancer Immunotherapies Revenue by Countries
6.1 Europe Cancer Immunotherapies Revenue by Countries (2013-2018)
6.2 Germany Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
6.3 UK Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
6.4 France Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
6.5 Russia Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
6.6 Italy Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Cancer Immunotherapies Revenue by Countries
7.1 Asia-Pacific Cancer Immunotherapies Revenue by Countries (2013-2018)
7.2 China Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
7.3 Japan Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
7.4 Korea Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
7.5 India Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
8 South America Cancer Immunotherapies Revenue by Countries
8.1 South America Cancer Immunotherapies Revenue by Countries (2013-2018)
8.2 Brazil Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
8.3 Argentina Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
8.4 Colombia Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Cancer Immunotherapies by Countries
9.1 Middle East and Africa Cancer Immunotherapies Revenue by Countries (2013-2018)
9.2 Saudi Arabia Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
9.3 UAE Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
9.4 Egypt Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
9.5 Nigeria Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
9.6 South Africa Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
10 Global Cancer Immunotherapies Market Segment by Type
10.1 Global Cancer Immunotherapies Revenue and Market Share by Type (2013-2018)
10.2 Global Cancer Immunotherapies Market Forecast by Type (2018-2023)
10.3 Monoclonal Antibodies Revenue Growth Rate (2013-2023)
10.4 Cancer Vaccines Revenue Growth Rate (2013-2023)
10.5 Check Point Inhibitors Revenue Growth Rate (2013-2023)
10.6 Immunomodulators Revenue Growth Rate (2013-2023)
11 Global Cancer Immunotherapies Market Segment by Application
11.1 Global Cancer Immunotherapies Revenue Market Share by Application (2013-2018)
11.2 Cancer Immunotherapies Market Forecast by Application (2018-2023)
11.3 Lung Revenue Growth (2013-2018)
11.4 Breast Revenue Growth (2013-2018)
11.5 Colorectal Revenue Growth (2013-2018)
11.6 Melanoma Revenue Growth (2013-2018)
11.7 Prostate Revenue Growth (2013-2018)
11.8 Head & Neck Revenue Growth (2013-2018)
12 Global Cancer Immunotherapies Market Size Forecast (2018-2023)
12.1 Global Cancer Immunotherapies Market Size Forecast (2018-2023)
12.2 Global Cancer Immunotherapies Market Forecast by Regions (2018-2023)
12.3 North America Cancer Immunotherapies Revenue Market Forecast (2018-2023)
12.4 Europe Cancer Immunotherapies Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Cancer Immunotherapies Revenue Market Forecast (2018-2023)
12.6 South America Cancer Immunotherapies Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Cancer Immunotherapies Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Cancer Immunotherapies Picture
Table Product Specifications of Cancer Immunotherapies
Table Global Cancer Immunotherapies and Revenue (Million USD) Market Split by Product Type
Figure Global Cancer Immunotherapies Revenue Market Share by Types in 2017
Figure Monoclonal Antibodies Picture
Figure Cancer Vaccines Picture
Figure Check Point Inhibitors Picture
Figure Immunomodulators Picture
Table Global Cancer Immunotherapies Revenue (Million USD) by Application (2013-2023)
Figure Cancer Immunotherapies Revenue Market Share by Applications in 2017
Figure Lung Picture
Figure Breast Picture
Figure Colorectal Picture
Figure Melanoma Picture
Figure Prostate Picture
Figure Head & Neck Picture
Table Global Market Cancer Immunotherapies Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Cancer Immunotherapies Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Cancer Immunotherapies Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Cancer Immunotherapies Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Cancer Immunotherapies Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Cancer Immunotherapies Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Cancer Immunotherapies Revenue (Million USD) and Growth Rate (2013-2023)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Cancer Immunotherapies Type and Applications
Table Amgen Cancer Immunotherapies Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol Mayer’s Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol Mayer’s Squibb Cancer Immunotherapies Type and Applications
Table Bristol Mayer’s Squibb Cancer Immunotherapies Revenue, Gross Margin and Market Share (2016-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Cancer Immunotherapies Type and Applications
Table F. Hoffmann-La Roche Cancer Immunotherapies Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Cancer Immunotherapies Type and Applications
Table Merck Cancer Immunotherapies Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Cancer Immunotherapies Type and Applications
Table Takeda Cancer Immunotherapies Revenue, Gross Margin and Market Share (2016-2017)
Table Global Cancer Immunotherapies Revenue (Million USD) by Players (2013-2018)
Table Global Cancer Immunotherapies Revenue Share by Players (2013-2018)
Figure Global Cancer Immunotherapies Revenue Share by Players in 2016
Figure Global Cancer Immunotherapies Revenue Share by Players in 2017
Figure Global Top 5 Players Cancer Immunotherapies Revenue Market Share in 2017
Figure Global Top 10 Players Cancer Immunotherapies Revenue Market Share in 2017
Figure Global Cancer Immunotherapies Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Cancer Immunotherapies Revenue (Million USD) by Regions (2013-2018)
Table Global Cancer Immunotherapies Revenue Market Share by Regions (2013-2018)
Figure Global Cancer Immunotherapies Revenue Market Share by Regions (2013-2018)
Figure Global Cancer Immunotherapies Revenue Market Share by Regions in 2017
Figure North America Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Figure Europe Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Figure South America Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Table North America Cancer Immunotherapies Revenue by Countries (2013-2018)
Table North America Cancer Immunotherapies Revenue Market Share by Countries (2013-2018)
Figure North America Cancer Immunotherapies Revenue Market Share by Countries (2013-2018)
Figure North America Cancer Immunotherapies Revenue Market Share by Countries in 2017
Figure USA Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Figure Canada Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Figure Mexico Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Table Europe Cancer Immunotherapies Revenue (Million USD) by Countries (2013-2018)
Figure Europe Cancer Immunotherapies Revenue Market Share by Countries (2013-2018)
Figure Europe Cancer Immunotherapies Revenue Market Share by Countries in 2017
Figure Germany Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Figure UK Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Figure France Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Figure Russia Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Figure Italy Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Cancer Immunotherapies Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Cancer Immunotherapies Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Cancer Immunotherapies Revenue Market Share by Countries in 2017
Figure China Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Figure Japan Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Figure Korea Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Figure India Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Table South America Cancer Immunotherapies Revenue by Countries (2013-2018)
Table South America Cancer Immunotherapies Revenue Market Share by Countries (2013-2018)
Figure South America Cancer Immunotherapies Revenue Market Share by Countries (2013-2018)
Figure South America Cancer Immunotherapies Revenue Market Share by Countries in 2017
Figure Brazil Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Figure Argentina Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Figure Colombia Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Cancer Immunotherapies Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Cancer Immunotherapies Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Cancer Immunotherapies Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Cancer Immunotherapies Revenue Market Share by Countries in 2017
Figure Saudi Arabia Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Figure UAE Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Figure Egypt Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Figure Nigeria Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Figure South Africa Cancer Immunotherapies Revenue and Growth Rate (2013-2018)
Table Global Cancer Immunotherapies Revenue (Million USD) by Type (2013-2018)
Table Global Cancer Immunotherapies Revenue Share by Type (2013-2018)
Figure Global Cancer Immunotherapies Revenue Share by Type (2013-2018)
Figure Global Cancer Immunotherapies Revenue Share by Type in 2017
Table Global Cancer Immunotherapies Revenue Forecast by Type (2018-2023)
Figure Global Cancer Immunotherapies Market Share Forecast by Type (2018-2023)
Figure Global Monoclonal Antibodies Revenue Growth Rate (2013-2018)
Figure Global Cancer Vaccines Revenue Growth Rate (2013-2018)
Figure Global Check Point Inhibitors Revenue Growth Rate (2013-2018)
Figure Global Immunomodulators Revenue Growth Rate (2013-2018)
Table Global Cancer Immunotherapies Revenue by Application (2013-2018)
Table Global Cancer Immunotherapies Revenue Share by Application (2013-2018)
Figure Global Cancer Immunotherapies Revenue Share by Application (2013-2018)
Figure Global Cancer Immunotherapies Revenue Share by Application in 2017
Table Global Cancer Immunotherapies Revenue Forecast by Application (2018-2023)
Figure Global Cancer Immunotherapies Market Share Forecast by Application (2018-2023)
Figure Global Lung Revenue Growth Rate (2013-2018)
Figure Global Breast Revenue Growth Rate (2013-2018)
Figure Global Colorectal Revenue Growth Rate (2013-2018)
Figure Global Melanoma Revenue Growth Rate (2013-2018)
Figure Global Prostate Revenue Growth Rate (2013-2018)
Figure Global Head & Neck Revenue Growth Rate (2013-2018)
Figure Global Cancer Immunotherapies Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Cancer Immunotherapies Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Cancer Immunotherapies Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Cancer Immunotherapies Revenue Market Forecast (2018-2023)
Figure Europe Cancer Immunotherapies Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Cancer Immunotherapies Revenue Market Forecast (2018-2023)
Figure South America Cancer Immunotherapies Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Cancer Immunotherapies Revenue Market Forecast (2018-2023)
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
